Fig. 1From: Clinical characteristics, healthcare use, and annual costs among patients with dystrophic epidermolysis bullosaPercentage of patients with select comorbidities during the 12-month follow-up (EHR data). DDEB dominant dystrophic epidermolysis bullosa, DEB dystrophic epidermolysis bullosa, EB epidermolysis bullosa, EHR electronic health record, RDEB recessive dystrophic epidermolysis bullosa, SCC squamous cell carcinomaBack to article page